A Blinded Longterm Ext Study to Eval the Safety and Efficacy of Pioglitazone (AD-4833 Sust Release 0.8 mg daily) to Slow the Progress of Cog Decline in Subj Who Have completed the AD4833/TOMM40_301 Study w/ Diag of Mild Cog Impair due to Alz Disease.
Administered By
Awarded By
Contributors
- Burke, James Robert Principal Investigator
Start/End
- April 1, 2015 - December 31, 2019